Skip to content

Clinical trials

Phase 1/2 Inflammation trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 1/2 Status: Unknown status Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20133
20141
20151
20162
20171
20192
20202
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fast Forward Pharmaceuticals2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Brian Miller1
E2Bio Life Sciences, LLC1
Karolinska Institutet1
LI Taisheng1
Queen Mary University of London1
Shanghai University of Traditional Chinese Medicine1
Soroka University Medical Center1
Taipei Medical University Shuang Ho Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation15
Acute Lung Injury1
Atherosclerosis1
Body Weight1
COVID-191
Carcinoma, Hepatocellular1
Coronavirus Infections1
Cough-Variant Asthma1
Crohn Disease1
Diabetes Mellitus1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.